Proxima is a bedside, patient-connected blood gas analyser offering critical results quicker, more often and with no downside to the patient or clinician. Getting patients into normal ranges quickly and keeping them there for longer is one of the goals of critical care medicine that Proxima will help achieve.
Conventional blood gas analysis results in patient blood loss which they cannot afford – Proxima returns all the blood which allows more frequent testing. Proxima is a closed system meaning that the additional testing possible with Proxima comes at no increased infection risk as the line stays closed.
All these benefits come at a cost that is comparable with conventional blood gas analysis with the future prospect of Proxima contributing to overall ICU performance improvement in length of stay, readmission rates, morbidity and mortality rates, transfusion reduction, infection costs reduction and overall consumable costs reduction.